NOTICE FROM THE OFFICE OF EXECUTIVE PROGRAMS, CENTER FOR DRUG EVALUATION AND RESEARCH, U.S. FOOD & DRUG ADMINISTRATION:
The FDA’s Office of Special Health Issues will be hosting a 1 hour webinar that will discuss Patient Advocacy. The discussion will include presentations from FDA staff and patient organizations on how they effectively worked with the FDA and other entities.
There will be an opportunity for those of you who live and struggle with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome to ask questions about patient advocacy and how to effectively work with government agencies and drug developers.
Unfortunately, we will not be able to answer specific questions about treatment options or development of new therapies for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.
Registration is limited to the first 250 registrants.
November 15, 2012
2:00 PM – 3:00 PM (Eastern Time Zone)